Global Melanocortin Receptor 4 Market Research Report 2021 - Impact of COVID-19 on the Market

Melanocortin 4 receptor is a protein that in humans is encoded by the MC4R gene. It encodes the MC4 protein, a G protein-coupled receptor that binds α-melanocyte stimulating hormone (α-MSH). In murine models MC4 receptors have been found to be involved in feeding behaviour, the regulation of metabolism, sexual behaviour, and male erectile function.In 2008, MC4R mutations were reported to be associated with inherited human obesity.[citation needed] They were found in heterozygotes, suggesting an autosomal dominant inheritance pattern. However, based on other research and observations, these mutations seem to have an incomplete penetrance and some degree of codominance. It has a prevalence of 1.0–2.5% in people with body mass indices greater than 30, making it the most commonly known genetic defect predisposing people to obesity.
The Melanocortin Receptor 4 market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Melanocortin Receptor 4 market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Melanocortin Receptor 4 Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Melanocortin Receptor 4 market are:
Mallinckrodt Plc
AstraZeneca Plc
Rhythm Pharmaceuticals, Inc.
Pfizer Inc.
Palatin Technologies, Inc.
Obexia AG
Retrophin Inc.

Most important types of Melanocortin Receptor 4 products covered in this report are:
Bremelanotide
Corticotropin
Cosyntropin
Others

Most widely used downstream fields of Melanocortin Receptor 4 market covered in this report are:
Metabolic Disorder
Womens Health
Genito Urinary System
Infection Disease
Others

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026